Dashboard
Manage Tickers

QDEL QUIDEL CORP /DE/

Nasdaq www.quidel.com


$ 27.68 $ 0.72 (2.67 %)    

Monday, 03-Nov-2025 16:04:57 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 629.78 $ -3.11 (-0.49 %)
DIA $ 472.70 $ -2.66 (-0.56 %)
SPY $ 681.88 $ -2.29 (-0.33 %)
TLT $ 89.68 $ 0.07 (0.08 %)
GLD $ 366.72 $ 0.05 (0.01 %)
$ 27.71
$ 27.00
$ 26.00 x 40
$ 28.00 x 74
$ 26.37 - $ 27.92
$ 22.05 - $ 49.45
1,547,934
na
1.16B
$ 0.78
$ 1.15
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-04-2022 03-31-2022 10-Q
2 02-18-2022 12-31-2021 10-K
3 11-04-2021 09-30-2021 10-Q
4 08-05-2021 06-30-2021 10-Q
5 05-07-2021 03-31-2021 10-Q
6 02-19-2021 12-31-2020 10-K
7 10-30-2020 09-30-2020 10-Q
8 07-31-2020 06-30-2020 10-Q
9 05-07-2020 03-31-2020 10-Q
10 02-13-2020 12-31-2019 10-K
11 10-31-2019 09-30-2019 10-Q
12 08-09-2019 06-30-2019 10-Q
13 05-09-2019 03-31-2019 10-Q
14 02-15-2019 12-31-2018 10-K
15 11-07-2018 09-30-2018 10-Q
16 08-08-2018 06-30-2018 10-Q
17 05-09-2018 03-31-2018 10-Q
18 02-27-2018 12-31-2017 10-K
19 11-02-2017 09-30-2017 10-Q
20 07-27-2017 06-30-2017 10-Q
21 04-27-2017 03-31-2017 10-Q
22 02-16-2017 12-31-2016 10-K
23 10-28-2016 09-30-2016 10-Q
24 07-28-2016 06-30-2016 10-Q
25 04-29-2016 03-31-2016 10-Q
26 02-23-2016 12-31-2015 10-K
27 10-29-2015 09-30-2015 10-Q
28 07-23-2015 06-30-2015 10-Q
29 04-24-2015 03-31-2015 10-Q
30 02-24-2015 12-31-2014 10-K
31 10-24-2014 09-30-2014 10-Q
32 07-24-2014 06-30-2014 10-Q
33 04-25-2014 03-31-2014 10-Q
34 02-27-2014 12-31-2013 10-K
35 10-25-2013 09-30-2013 10-Q
36 07-31-2013 06-30-2013 10-Q
37 04-24-2013 03-31-2013 10-Q
38 02-22-2013 12-31-2012 10-K
39 10-29-2012 09-30-2012 10-Q
40 07-27-2012 06-30-2012 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

quidelortho-receives-fda-510k-clearance-for-vitros-immunodiagnostic-products-hs-troponin-i-assay
QuidelOrtho Receives FDA 510(k) Clearance ...
11/03/2025 12:17:45

why-is-co-diagnostics-stock-sinking-tuesday
Why Is Co-Diagnostics Stock Sinking Tuesday?
10/28/2025 15:50:49

Co-Diagnostics (CODX) stock falls over 50% as they announced a $7 million offering and Saudi joint venture, causing concerns ab...

reported-earlier-quidelortho-highlights-fda-approved-mts-dat-card-and-ortho-vision-platform-advancing-transfusion-medicine-at-aabb-2025
Reported Earlier, QuidelOrtho Highlights F...
10/17/2025 05:59:17

FDA-approved MTS™ DAT Card and advanced ORTHO VISION™ Platform highlight the company's continued leadership in transfusion ...

amd-to-rally-more-than-47-here-are-10-top-analyst-forecasts-for-tuesday
AMD To Rally More Than 47%? Here Are 10 To...
10/07/2025 12:13:15

citigroup-downgrades-quidelortho-to-neutral-lowers-price-target-to-33
Citigroup Downgrades QuidelOrtho to Neutra...
10/07/2025 11:25:09

Citigroup analyst Patrick Donnelly downgrades QuidelOrtho (NASDAQ:QDEL) from Buy to Neutral and lowers the price target from...

quidelortho-expands-quickvue-portfolio-with-launch-of-influenza-plus-sars-test-delivering-results-in-as-fast-as-10-minutes
QuidelOrtho Expands QUICKVUE Portfolio Wit...
09/22/2025 11:13:00

Key Features and Benefits:Triple Detection Capability: Differentiates influenza A/B and COVID-19 in one test.Fast Results: Clea...

ubs-maintains-neutral-on-quidelortho-lowers-price-target-to-26
UBS Maintains Neutral on QuidelOrtho, Lowe...
08/07/2025 17:37:50

UBS analyst Lu Li maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and lowers the price target from $29 to $26.

citigroup-maintains-buy-on-quidelortho-lowers-price-target-to-40
Citigroup Maintains Buy on QuidelOrtho, Lo...
08/06/2025 21:56:43

Citigroup analyst Patrick Donnelly maintains QuidelOrtho (NASDAQ:QDEL) with a Buy and lowers the price target from $50 to $40.

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/05/2025 21:07:20

quidelortho-affirms-fy2025-adj-eps-guidance-of-207-257-vs-240-est-affirms-fy2025-sales-guidance-of-2600b-2810b-vs-2714b-est
QuidelOrtho Affirms FY2025 Adj EPS Guidanc...
08/05/2025 20:21:23

QuidelOrtho (NASDAQ:QDEL) affirms FY2025 Adj EPS guidance from $2.07-$2.57 to $2.07-$2.57 vs $2.40 analyst estimate. Affirms FY...

quidelortho-q2-adj-eps-012-beats-001-estimate-sales-613900m-beat-609978m-estimate
QuidelOrtho Q2 Adj. EPS $0.12 Beats $0.01 ...
08/05/2025 20:11:03

QuidelOrtho (NASDAQ:QDEL) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.01 by ...

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

quidelortho-and-bhlmann-expand-access-to-fecal-biomarker-testing-with-integration-of-turbo-assays-on-vitros-platforms
QuidelOrtho And BÜHLMANN Expand Access To ...
07/14/2025 11:07:22

Gastrointestinal biomarker tests enhance patient diagnosis of IBD and pancreatic insufficiency on leading clinical chemistry pl...

crowdstrike-asana-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
CrowdStrike, Asana And Other Big Stocks Mo...
06/04/2025 09:23:53

ubs-maintains-neutral-on-quidelortho-lowers-price-target-to-29
UBS Maintains Neutral on QuidelOrtho, Lowe...
05/08/2025 18:49:21

UBS analyst Lu Li maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and lowers the price target from $45 to $29.

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/08/2025 17:06:16

jefferies-upgrades-quidelortho-to-buy-announces-44-price-target
Jefferies Upgrades QuidelOrtho to Buy, Ann...
05/08/2025 16:14:40

Jefferies analyst Tycho Peterson upgrades QuidelOrtho (NASDAQ:QDEL) from Hold to Buy and announces $44 price target.

groupon-posts-upbeat-earnings-joins-axon-enterprise-warner-bros-discovery-mercadolibre-and-other-big-stocks-moving-higher-on-thursday
Groupon Posts Upbeat Earnings, Joins Axon ...
05/08/2025 14:11:47

quidelortho-affirms-fy2025-adj-eps-guidance-of-207-257-vs-325-est-affirms-fy2025-sales-guidance-of-260b-281b-vs-281b-est
QuidelOrtho Affirms FY2025 Adj EPS Guidanc...
05/07/2025 20:07:28

QuidelOrtho (NASDAQ:QDEL) affirms FY2025 Adj EPS guidance from $2.07-$2.57 to $2.07-$2.57 vs $3.25 analyst estimate. Affirms FY...

quidelortho-q1-adj-eps-074-beats-011-estimate-sales-69280m-beat-62232m-estimate
QuidelOrtho Q1 Adj. EPS $0.74 Beats $0.11 ...
05/07/2025 20:06:52

QuidelOrtho (NASDAQ:QDEL) reported quarterly earnings of $0.74 per share which beat the analyst consensus estimate of $0.11 by ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION